
Germany · Environmental services startup
Cerafiltec, officially known as Cerafiltec Germany GmbH, is a global technology provider based in Saarbrücken, Germany.
Funding reportedLast round: Private equity
Cerafiltec, officially known as Cerafiltec Germany GmbH, is a global technology provider based in Saarbrücken, Germany.
Founded in 2016, the company specializes in high-performance ceramic flat sheet membrane filtration technologies for water and wastewater treatment. With a team of 51 to 200 employees, Cerafiltec leverages over 25 years of industry experience to deliver innovative and sustainable solutions that enhance water quality and accessibility. The company offers a range of advanced products, including ceramic flat sheet membrane modules, submerged ceramic membrane bioreactor systems, and complete filtration systems tailored for various applications. Cerafiltec's technology is recognized for its superior filtration efficiency, durability, and lower environmental impact compared to traditional polymeric membranes. The company serves diverse sectors, including municipal wastewater reuse, drinking water production, and industrial applications, with a strong global presence across multiple regions. Cerafiltec is committed to enabling access to clean water worldwide through its reliable and efficient filtration technologies.
Funding, as reported
What they build
Known for
ultra filtrationceramic flat sheetwater utilitieswater reuseexchangeable ceramic platesair-scouring backwashmanufacturingsustainable water solutionspre-treatment processdesign engineeringceramic membrane technologynsf 61 certificationpore size 0.05-0.5 micronceramic membrane for sewage reusegroundwater treatmentplant operation monitoring
Built with from their website
Google Tag ManagerWordPress.orgPWAVtiger CRMConcurYouTubeCloudflare DNSUsercentricsOloCloudFlare
Viewport MetaHTTP/3Cloudflare Rocket LoaderHubspotVimeoHornetsecurity Spam and Malware ProtectionFacebook SDKSentry
Add your raise, your deck and your story, and put Cerafiltec in front of investors. Or tell us what we have wrong.